HK Stock Market Move | YESTAR HEALTH(02393) rose more than 17% during intraday trading and is currently considering forming a joint venture with Genetron Health in Singapore.

YESTAR HEALTH (02393) rose more than 17% in midday trading, and as of the time of writing, it was up 17.69% at HK$0.153, with a turnover of HK$4.8978 million. On the news front, on October 20, YESTAR HEALTH announced that the company is currently considering forming a joint venture (proposed joint venture) with New Genetron Holding Limited (Genetron Health) in Singapore, and may expand its business in Indonesia, Malaysia, and Singapore. According to the current plan, the proposed joint venture will establish a new entity in Indonesia that will specialize in designing, constructing, and operating clinical molecular diagnostic laboratories with a focus on precision oncology, and may establish production facilities for in vitro diagnostic reagents and assay kits locally when necessary. In other words, the proposed joint venture will establish an advanced medical laboratory in Indonesia to provide advanced genetic testing, including cancer screening, to help doctors detect diseases early and tailor treatment plans for patients. The proposed joint venture will focus on providing advanced molecular diagnostics services (using cutting-edge laboratory testing to analyze and understand diseases at the molecular level), especially in the field of precision oncology (providing personalized cancer care tailored to each patient's unique genetic mutations and cancer types).